At all embryo stages, significant differences were noted between the CRH 107 and control groups as well as be- tween the CRH 107 and CRH 107/antalarmin 106 groups, with the rates being lower in the former.
With regard to the morula/blastocyst stage, the rates in the CRH 107 group were lower compared with the control (P 0.003) and lower compared with the CRH 107/antalarmin 106 group (P 0.001) (Table 2).
Interestingly, the addition of a 10-fold excess of the CRH-R1 antagonist, antalarmin, overcame the negative effect of CRH on estradiol release (d 5, P 0.009; d 7, P 0.010; d 9, P 0.001; and d 11, P 0.002), indicating that the suppressive effect of CRH was receptor mediated (Fig. 1).
The addition of the CRH-R1 an- tagonist antalarmin in a 10-fold higher concentration compared with that of CRH overcame the effect of CRH on beta-hCG release (d 11 beta-hCG 185.6 6.087 mIU/ml, P 0.001) indicating that the suppressive effect of CRH was recep- tor mediated (Fig. 3).
The addition of a 10-fold excess of the CRH-R1 antagonist antalarmin reversed the negative ef- fect of CRH on progesterone release (d 11 progesterone 0.712 0.004 ng/ml, P 0.001), suggesting that the suppressive effect of CRH was receptor mediated (Fig. 2).
The addition of the CRH-R1 an- tagonist antalarmin in a 10-fold higher concentration compared with that of CRH overcame the effect of CRH on -hCG release (d 11 beta-hCG 185.6 6.087 mIU/ml, P 0.001) indicating that the suppressive effect of CRH was recep- tor mediated (Fig. 3).
In the CRH 107 mol/liter group, the amount of beta-hCG measured in the culture medium was elevated but to a lesser extent compared with the control group (d 11 -hCG 6.05 0.077 mIU/ml, P 0.001).
Notably, CRH did not affect the amount of progesterone released into the incubation medium up to d 9, whereas it suppressed pro- gesterone levels on d 11 (d 11 progesterone 0.030 0.000 ng/ml, P 0.001).
BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.
If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.